Mortality After Endoscopic Retrograde Cholangiopancreatography

Patients With Mortality After Endoscopic Retrograde Cholangiopancreatography

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02983331

Enrollment

1471

Registered

2016-12-06

Start date

2016-04-30

Completion date

2016-05-31

Last updated

2016-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholangiopancreatography, Endoscopic Retrograde, Deep Sedation, Mortality

Brief summary

In this study, the investigators aimed to overview patients with specific and non-specific complications who admitted to intensive care unit following endoscopic retrograde cholangiopancreatography and had fatal course in the facility

Detailed description

The investigators retrospectively reviewed patients who underwent elective or emergent endoscopic retrograde cholangiopancreatography at semi-prone position under pharyngeal anesthesia (lidocaine spray) with routine monitoring (including electrocardiography, non-invasive blood pressure, peripheral capillary oxygen saturation) and standard sedation protocol (midazolam 0.02 mgkg-1; fentanyl, 1 mgkg-1; propofol 1 mgkg-1) between 2011 and 2016 after approval of local ethics committee of Umraniye Training Hospital.

Interventions

PROCEDUREcomplications during procedure

patients may have anesthesia related complications during procedure

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

42 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Patients who underwent elective or emergent ERCP at semi-prone position with routine monitoring and standard sedation protocol

Exclusion criteria

* Patients who discharged to ward after treatment and follow-up in ICU

Design outcomes

Primary

Measure	Time frame	Description
Number of Participants With endoscopic retrograde cholangiopancreatography Related complications	5 years	We retrospectively reviewed patients who underwent elective or emergent endoscopic retrograde cholangiopancreatography at semi-prone position under pharyngeal anesthesia (lidocaine spray) with routine monitoring (including electrocardiography, non-invasive blood pressure, peripheral capillary oxygen saturation) and standard sedation protocol
Rate of anaesthesia related mortality of the endoscopic retrograde cholangiopancreatographyprocedure under sedation	5 years	We identified patients who developed complications during procedure and admitted to intensive care unit (ICU).

Secondary

Measure	Time frame
Value of Acute Physiology and Chronic Health Evaluation (APACHE II) score for predicting mortality	5 years
Value of Charlson comorbidity index (CCI) score for predicting mortality	5 years

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026